SCHEMBL6793542

SCHEMBL6793542

NCc1ccc(/C(N)=N/OC(=O)OCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 5/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.47
THRB P10828 1/20 0.47
KDM4E B2RXH2 1/20 0.47
HTT P42858 1/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
PKM P14618 2/20 0.45
LMNA P02545 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8363701 1.00 L3MBTL1 (0.49) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
SCHEMBL6793545 1.00 L3MBTL1 (0.49) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
SCHEMBL23486912 0.86 L3MBTL1 (0.67) L3MBTL1SMN1; SMN2MAPK1TDP1MAPT
SCHEMBL25489140 0.83 TNF (0.64) L3MBTL1SMN1; SMN2MAPK1TDP1MAPT
SCHEMBL5045569 0.82 LMNA (0.45) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
SCHEMBL5177381 0.82 LMNA (0.45) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
SCHEMBL8363638 0.81 SMN1; SMN2 (0.50) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
SCHEMBL10054644 0.81 SMN1; SMN2 (0.50) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
Hydrochloric Acid SCHEMBL5045565 0.81 MAOB (0.45) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A
Hydrochloric Acid SCHEMBL5045567 0.81 MAOB (0.45) L3MBTL1SMN1; SMN2MAPK1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082585-A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082585-A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade TFPI, F2, PLG L3MBTL1 1399/4885SMN1; SMN2 4186/4885MAPK1 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.